Previous 10 |
home / stock / cph:cc / cph:cc news
Cipher Pharmaceuticals Reports Strong First Quarter 2022 Financial Results Canada NewsWire (All figures are in U.S. dollars) Drove 60% increase in EPS to $0.08 Demonstrated a focus on execution as EBITDA increased 38% to $3.1 million T...
Cipher Pharmaceuticals Schedules Q1 2022 Earnings Release and Conference Call Canada NewsWire OAKVILLE, ON , May 9, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or " the Company ") today announced that it will release its ...
Cipher Pharmaceuticals Announces Partner, Moberg Pharma's Regulatory Submission to FDA for North American Phase 3 Study Canada NewsWire MISSISSAUGA, ON , March 22, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or " the Company ")...
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results Canada NewsWire Demonstrated growth in FY 2021 as EBITDA increased 46% to $11.8 million Disciplined cost structure led to an 18% reduction in SG&A 81% increase ...
News, Short Squeeze, Breakout and More Instantly...
Cipher Pharmaceuticals Inc. Company Name:
CPH:CC Stock Symbol:
TSXC Market:
Cipher Pharmaceuticals Inc. Website:
Cipher Pharmaceuticals Reports First Quarter 2024 Results Canada NewsWire (All figures are presented in U.S. Dollars) Adjusted EBITDA in Q1 2024 was $3.6 million , an increase of 12.5% over Q1 2023 Epuris sales volumes grew 7.2% in the quarter over Q1 2023, c...
Gold Springs Resource Corp. (GRC:CA) is expected to report for Q1 2024 Primo Water Corporation (PRMW:CA) is expected to report $0.18 for Q1 2024 Greenlane Renewables Inc. (GRN:CA) is expected to report $-0.01 for Q1 2024 Kelso Technologies Inc. (KLS:CA) is expected to report for Q1 20...
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , May 3, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release ...